Price $15.15 |
Market Cap
671M
|
Sector Health Care |
Div. Growth
-9.40%
|
|
P/E
22.4
|
P/B
3.89
|
P/S
3.35
|
Dividend %
3.20%
|
|
P/CF
115.6
|
P/FCF
77.8
|
Op. Cash Flow
43.9K
|
FCF
0.2
|
|
Op. Margin
23.60%
|
Net Margin
15.00%
|
ROE
17.80%
|
ROI
14.70%
|
|
ROA
11.80%
|
EPS Growth
-16.60%
|
Current Ratio
5.6
|
Debt/Equity
32.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.43 | - | - | 91.5M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.21 | - | - | 30.8M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.45 | - | - | 4M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.75 | - | 6.50% | 25.1M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.80 | - | - | 1.27B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
